NEUE Earnings Prediction
The chart below shows how NEUE performed 10 days before and after its earnings report, based on data from the past quarters. Typically, NEUE sees a -5.50% change in stock price 10 days leading up to the earnings, and a -13.40% change 10 days following the report. On the earnings day itself, the stock moves by +5.52%. This data can give you a slight idea of what to expect for the next quarter's release.
NEUE Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
232.93M
-13.54%
3.07%
Gross Margin
--
--
--
Operating Margin
-5.88%
-66.42%
-32.88%
Net Margin
-11.17%
-93.72%
-35.69%
EPS
-8.51
-89.50%
-1.62%
No Data Available
NEUE Earnings Analysis
NeueHealth, Inc. Corporation (NEUE.N) Earnings Conference Call
Positive
Record Financial Performance: Neue Health delivered its strongest financial performance to date in the third quarter, generating $9.4 million of adjusted EBITDA.
Adjusted EBITDA Profitability: For three consecutive quarters, Neue Health has driven adjusted EBITDA profitability, generating $17 million of adjusted EBITDA through the first three quarters of 2024.
Consumer Growth Achievement: This quarter, we grew the number of consumers we served across our Neue Care and Neue Solutions segments, serving approximately 509,000 consumers in total, slightly above our guidance range for the full year.
Future Growth Outlook: Overall, we believe we are well positioned to finish 2024 on a strong note, with expectations for continued success and growth in 2025.
Q3 Revenue Performance: In the third quarter, Neue Care delivered revenue of $83.9 million with medical costs and operating costs approximately in line with expectations for the quarter.
Negative
Revenue and Profitability Challenges: Nue Health's consolidated revenue for the third quarter was $232.9 million, with a gross margin of $50.2 million, indicating potential challenges in maintaining profitability.
Adjusted EBITDA Performance: Nue Health delivered adjusted EBITDA of $9.4 million in the third quarter, which, while exceeding expectations, reflects a decline compared to previous quarters.
NeuCare Revenue and Margins: The NeuCare segment generated revenue of $83.9 million, but the operating income was only $16.4 million, suggesting pressure on margins in this segment.
Operating Loss Report: Nue Solutions segment reported an operating loss of $5.8 million for the third quarter, highlighting ongoing financial struggles in this area.
Operating Cost Challenges: The company expects adjusted operating costs to be between 19% to 20%, which may indicate rising operational inefficiencies and cost management challenges.
NEUE FAQs
How does NEUE typically perform around its earnings report dates?
Is NeueHealth, Inc. (NEUE) Q3 2024 Earnings Conference Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
NEUE Earning Call Sentiment
NeueHealth, Inc. (NEUE) Q3 2024 Earnings Conference Call Transcript
1.0x
00:00
00:00
NEUE.N
-1.22%Positive
The earnings call summary presents a mixed picture: strong consumer growth and solid financial performance, but challenges with ACA insurance wind-down and economic uncertainties. The Q&A section lacks clarity, failing to address concerns adequately. Despite positive EBITDA and revenue growth, the lack of new partnerships or strong guidance adjustments limits positive sentiment. The market may react neutrally over the next two weeks, as strengths are balanced by risks and uncertainties.
